Onkos Wins FDA Clearance to Expand NanoCept Coating
Parsippany, New Jersey, USA, November 6, 2026 Onkos Surgical, Inc., a medical technology company specializing in advanced solutions for...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Parsippany, New Jersey, USA, November 6, 2026 Onkos Surgical, Inc., a medical technology company specializing in advanced solutions for...
PARSIPPANY, N.J., June 8, 2026 Onkos Surgical announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
